Now showing items 1-2 of 2

    • Clinical features and HLA association of 5-Aminosalicylate (5-ASA) induced nephrotoxicity in inflammatory bowel disease. 

      Heap, Graham A.; So, K; Weedon, M; Edney, Naomi; Bewshea, Claire; Singh, Abhey; Annese, V; Beckly, J; Buurman, D; Chaudhary, R; Cole, A T; Cooper, S C; Creed, T.; Cummings, F; de Boer, N K; D'Inca, R; D'Souza, Richard; Daneshmend, T K; Delaney, M; Dhar, A; Direkze, N; Dunckley, P; Gaya, D R; Gearry, R; Gore, S; Halfvarsson, J; Hart, A; Hawkey, C J; Hoentjen, F; Iqbal, T; Irving, P; Lal, S; Lawrance, I; Lees, C W; Lewis, S; Lockett, M; Mann, S; Mansfield, J; Mowat, C; Mulgrew, Christopher J; Muller, F; Murray, C; Oram, Richard; Orchard, T; Parkes, M; Phillips, R; Pollok, R; Radford-Smith, G; Sebastian, S; Sen, S; Shirazi, T; Silverberg, M; Solomon, L; Sturniolo, G C; Thomas, M; Tremelling, M; Tsianos, E V; Watts, D; Weaver, S; Weersma, R K; Wesley, E; Holden, Ar; Ahmad, Tariq (Oxford University Press, 2015-11-29)
      Background & AimsNephrotoxicity is a rare idiosyncratic reaction to 5-aminosalicylate (5-ASA) therapies. The aims of this study were to describe the clinical features of this complication and identify clinically useful ...
    • Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial 

      D'Souza, Richard (Elsevier Science, 2020-05-02)
      Background: Catheter-based renal denervation has significantly reduced blood pressure in previous studies. Following a positive pilot trial, the SPYRAL HTN-OFF MED (SPYRAL Pivotal) trial was designed to assess the efficacy ...